source
- Regulatory update: Hepatitis B hold lifted for Arbutus drug and Ultomiris receives accelerated approvalA regulatory update notes that the FDA has removed the clinical hold on Arbutus Biopharma's hepatitis B candidate, clearing the path for the company to resume development after a prolonged review.…
- Medrio aims to unify clinical trial tools to ease complexity for biotech firmsMike Novotny, founder and CEO of Medrio, says that funding cycles, growing study complexity and fragmented technology are slowing clinical research, especially for small and midsize life‑science co…